BioPorto A/S: directors' dealings · Denmark · Finanstilsynet DK DK:bioporto-as DK0011048619 DK DK · Finanstilsynet DK Mcap 604M€ Healthcare
Explore the full directors' dealings record of BioPorto A/S, a listed issuer based in Denmark. Shares are listed on DK DK, under the oversight of Finanstilsynet DK. Operating in the Healthcare sector, BioPorto A/S has logged 30 public disclosures. Market capitalisation: €604m. The latest transaction was reported on 24 November 2025 — Subscription. Among the most active insiders: Unknown. The full history is openly available.
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts · 1.75 € Target 1.75 €(+43%) 1.75 €
Income statement
Revenue 40.3 M€
Gross profit 30.4 M€ 75% margin
Net income −82.1 M€ -203.8% margin
Valuation
PER (forward) -17.4x
P/Book 9.6x
Beta 1.28
Balance sheet & cash
Market cap 604.0 M€
Total debt 7.5 M€
Free Cash Flow −77.1 M€
Debt / Equity 12%
Profitability & ownership
ROE -125.6%
ROA -51.8%
% insiders 29.8%
% institutions 6.2%
Last declaration on 24 November 2025
Declarations 30 total
Executives ● Subscription14 DK FSA
€401,634 72 shares @ €0.1339 0.066% mcap 1.2% of flow DK0064642466⌘
Share DK:1402296 · 24 Nov 2025
Executives ● Sale19 DK FSA
€3m 60,227 shares @ €50.8285 0.51% mcap 9.2% of flow
Share DK:1034031 · 25 May 2021
Executives ● Subscription32 DK FSA
U
Unknown Chairman of the Board of Directors €8m 150,000 shares @ €53.1861 1.32% mcap 24.1% of flow DK0011048619⌘
Share DK:895526 · 28 Jun 2019
Executives ● Subscription35 DK FSA
U
Unknown Chairman of the Board of Directors €13m 254,453 shares @ €52.6856 2.22% mcap 40.5% of flow DK0011048619⌘
Share DK:863196 · 12 Nov 2018
Executives ● Purchase20 DK FSA
€4m 100,000 shares @ €41.1325 0.68% mcap 12.4% of flow DK0011048619⌘
Share DK:786557 · 10 Aug 2017
Ideal exit: 7 May 2018 (T+270) Executives ● Purchase20 DK FSA
€4m 100,000 shares @ €41.1325 0.68% mcap 12.4% of flow DK0011048619⌘
Share DK:786547 · 10 Aug 2017
Ideal exit: 7 May 2018 (T+270) Executives ● Purchase8 DK FSA
€22,703 100,000 shares @ €0.227 0.0038% mcap 0.1% of flow DK0011048619⌘
Share DK:745848 · 14 Nov 2016
Ideal exit: 11 Aug 2017 (T+270) Executives ● Other8 DK FSA
Share
DK:705282 · 8 Apr 2016
Executives ● Other8 DK FSA
Share
DK:705009 · 6 Apr 2016
Executives ● Other8 DK FSA
Share
DK:600799 · 25 Mar 2014
Executives ● Other5 DK FSA
Share
DK:572761 · 12 Sept 2013
Executives ● Other5 DK FSA
Share
DK:570338 · 26 Aug 2013
Executives ● Other5 DK FSA
Share
DK:569444 · 20 Aug 2013
Executives ● Other5 DK FSA
Share
DK:519037 · 24 Aug 2012
Executives ● Other8 DK FSA
Share
DK:447753 · 8 Apr 2011
Executives ● Other8 DK FSA
Share
DK:393305 · 26 Mar 2010
Executives ● Other5 DK FSA
Share
DK:331795 · 25 Jun 2009
Executives ● Other5 DK FSA
Share
DK:330179 · 9 Jun 2009
Executives ● Other5 DK FSA
Share
DK:328925 · 28 May 2009
Executives ● Other5 DK FSA
Share
DK:320054 · 2 Apr 2009
Executives ● Other5 DK FSA
Share
DK:318634 · 26 Mar 2009
Executives ● Other5 DK FSA
Share
DK:318294 · 25 Mar 2009
Executives ● Other5 DK FSA
Share
DK:317962 · 24 Mar 2009
Executives ● Other5 DK FSA
Share
DK:317733 · 23 Mar 2009
Executives ● Other5 DK FSA
Share
DK:305261 · 22 Dec 2008
25 of 30 declarations
Load more (5 remaining) About BioPorto A/S BioPorto A/S is a Danish company specializing in the development of medical diagnostics. It focuses on innovative tests for serious diseases, particularly kidney disorders.
